Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity (SAF DER ASSESS)

January 5, 2017 updated by: Kley Hertz S/A
The purpose of this study is to prove the product tested does not cause photoirritation or photosensitization reactions when exposed to sun light.

Study Overview

Status

Unknown

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

28

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age between 18 to 70 years old;
  • Skin types: I (light caucasian) or III (light brown);
  • Intact skin where the product will be applied;
  • Agreement to comply with the test procedures and attend the clinic in the days and fixed times for medical assessments and application and reading of dressings
  • Signature of informed consent form

Exclusion Criteria:

  • Pregnancy and lactation
  • Use of anti-inflammatory and immunosuppressive from 30 days up to three months prior to selection;
  • Diseases that cause immune suppression;
  • Use of photosensitizing drugs;
  • History or photodermatoses activities;
  • Personal or family history of photoinduced skin cancer;
  • Presence of precursor lesions of skin cancer, such as melanocytic nevi and actinic keratoses;
  • Intense sun exposure in the experiment area Use of new drugs and/or cosmetics during the experiment;
  • Previous participation in a study with the same product under test;
  • Relevant medical history or current evidence of alcohol or other drugs abuse;
  • Known historical or suspected intolerance to any ingredient of the product under study (product under test or comparator);
  • Sponsor's employees involved in the study, or close family member of an employee involved in the study;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Experimental group
This study is designed as a single group assignment, because the 4 dressings (3 placebos and 1 containing the product) will be applied in all volunteers. This means that the region in which the tested product will be applied will be compared with the other placebo regions in the same volunteer.
All the volunteers will receive the application of four dressings (3 placebos and 1 containing the tested product). After a certain period of time, photoirritation and photosensitization will be measured through the evaluation of tested region.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Photoirritation as measured through the use of dressings containing tested product and placebo
Time Frame: 5 days
The photoirritation will be measured with the use of four dressings that will be applied in the volunteer (3 dresssings containing different placebos and 1 containing the product). After some hours, the region is evaluated and radiated with UVA. That procedure occurs during the period of five days.
5 days
Photosensitization as measured through the use of dressings containing tested product and placebo
Time Frame: 32 days
The photosensitization will be measured with the use of four dressings that will be applied in the volunteer (3 dresssings containing different placebos and 1 containing the product). After some hours, the region is evaluated and radiated with UVA. That procedure occurs during the period of 32 days.
32 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2017

Primary Completion (ANTICIPATED)

February 1, 2017

Study Registration Dates

First Submitted

December 29, 2016

First Submitted That Met QC Criteria

January 5, 2017

First Posted (ESTIMATE)

January 9, 2017

Study Record Updates

Last Update Posted (ESTIMATE)

January 9, 2017

Last Update Submitted That Met QC Criteria

January 5, 2017

Last Verified

December 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • Kley Hertz 006

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Skin Irritability

Clinical Trials on Intimate Lubrificant Gel

Subscribe